Sugi Predict

Sugi Predict / Compounds / Gluconic Acid

Gluconic Acid

Gluconic Acid

SCHEMBL826558

O=C(O[C@@H](C(=O)[O-])[C@@H](O)[C@H](O)[C@H](O)CO)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Fe+3].[Fe]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.62
▸ PDE4A P27815 1/20 0.47
▸ USP2 O75604 1/20 0.37
▸ SLCO1B1 Q9Y6L6 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL3710793 0.95 LMNA (0.65) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL2229853 0.95 LMNA (0.65) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL547729 0.94 LMNA (0.62) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Silver SCHEMBL18889837 0.92 LMNA (0.58) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL9142009 0.91 LMNA (0.59) LMNAPDE4AUSP2SLCO1B1L3MBTL1
SCHEMBL9360101 0.90 LMNA (0.56) LMNAPDE4AUSP2SLCO1B1L3MBTL1
SCHEMBL9142871 0.89 PDE4A (0.59) LMNAPDE4AUSP2SLCO1B1L3MBTL1
SCHEMBL9356215 0.89 PDE4A (0.59) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Potassium Ion SCHEMBL30209157 0.89 PDE4A (0.59) LMNAPDE4AUSP2SLCO1B1L3MBTL1
Gluconic Acid SCHEMBL2532981 0.87 LMNA (0.67) LMNAPDE4AUSP2SLCO1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011156563-A2 ORAL IRON DEFICIENCY THERAPY EMISPHERE TECHNOLOGIES, INC. (US) 2011-12-15 — — WO disclosed